This topic contains a solution. Click here to go to the answer

Author Question: Why is it important for the interdisciplinary team to assess an older patient's level of pain? 1. ... (Read 74 times)

burchfield96

  • Hero Member
  • *****
  • Posts: 610
Why is it important for the interdisciplinary team to assess an older patient's level of pain?
 
  1. Validate that the pain is real.
  2. Ensure pain management is provided.
  3. Differentiate pain symptoms from other symptoms.
  4. Provide the appropriate amount of help for normal activities.

Question 2

A patient with a diagnosis of deep vein thrombosis (DVT) is being treated with unfractionated heparin, which is being administered intravenously. The nurse who is providing care for this patient should consequently prioritize what assessments?
 
  A) Assessing the patient for internal or external hemorrhage
  B) Monitoring the patient's intake and output, and assessing for signs of fluid volume deficit
  C) Assessing the patient for adventitious lung sounds and assessing SaO2 levels
  D) Assessing the patient's pain levels



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yeungji

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

2
Rationale: A pain assessment is done to address symptom relief or pain management and not to validate that the pain is real.

Answer to Question 2

A





 

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library